在患有间歇性肺部疾病的患者中,托西利祖马布对类风湿性关节炎的安全性
Naotatsu Otsuji1, Kumiya Sugiyama1,2, Takayoshi Owada1
1Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan.
Open access rheumatology : research and reviews
|June 17, 2024
概括
托西利祖马布在六个月内改善了类风湿性关节炎 (RA) 和间歇性肺病 (ILD) 的生物标志物. 然而,呼吸道感染随着时间的推移增加了ILD恶化和死亡率,突出了RA-ILD患者早期感染检测的必要性.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 风湿性关节炎 (RA) 与间歇性肺病 (ILD) 的预后不好.
- 需要有效的RA治疗方法,这些治疗方法不会使ILD恶化.
- 托西利祖马布对RA患者ILD活性的影响需要评估.
研究的目的:
- 评估托西利祖马布在RA和ILD患者中的安全性和有效性.
- 使用生物标志物评估托西利祖马布对ILD活性的影响.
主要方法:
- 对55名患有ILD的RA患者进行前性研究,这些患者接受了tocilizumab治疗.
- 测量MMP-3 (RA活动) 和KL-6 (ILD活动) 作为生物标志物.
- 分析了MMP-3,KL-6和ILD进展之间的关系.
主要成果:
- 托西利祖马布在6个月后显著改善了MMP-3和KL-6水平.
- RA 活性与 ILD 活性相关,在渐进性 RA 中 KL-6 较高.
- ILD进展与较高的MMP-3相关;死亡率在1年后增加,主要是由于呼吸道感染.
结论:
- 托西利祖马布改善了RA和ILD生物标志物,这表明它不会直接恶化ILD.
- 呼吸道感染是一个重要的风险,加剧ILD和增加死亡率.
- 早期识别呼吸道感染对于管理RA-ILD患者的免疫抑制剂如tocilizumab至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195